INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-18-00411

To nurture a snake in one’s bosom: aspiration of a giant right atrium thrombus after a MitraClip procedure

Jean-Michel Paradis*, MD; Kim O’Connor, MD; Luis Asmarats, MD; Josep Rodés-Cabau, MD

Figure 1. Picture of the catheter-related thrombus (measuring at least 27 cm), which remained almost completely intact despite the aspiration process.

A 90-year-old man, with a past medical history significant for type 2 diabetes mellitus, atrial fibrillation, chronic lymphocytic leukaemia, and prior sutureless aortic valve replacement with a Perceval valve (Sorin Group, Saluggia, Italy), was admitted to our institution because of decompensated heart failure caused by severe degenerative mitral regurgitation (MR). The Heart Team deemed the patient to be at very high risk for a reoperative open heart surgery. Hence, he was referred for a MitraClip® (Abbott Vascular, Santa Clara, CA, USA) procedure. The MR was significantly reduced after the deployment of one clip. The 24 Fr steerable guide catheter was thus removed from the right femoral vein. Despite appropriate flushing of the guide catheter and adequate anticoagulation with intravenous heparin during the entire MitraClip procedure (ACT >250 sec), a giant, very mobile, moulding thrombus of the steerable guide catheter was seen in the right atrium on transoesophageal echocardiography (Moving image 1). Through a long 14 Fr sheath placed in the left femoral vein, we were able to aspirate the 27 cm catheter-related “snake-like” thrombus completely (Figure 1). The patient was rapidly extubated. A ventilation perfusion scan did not reveal any signs of pulmonary embolism. The patient was put on IV heparin after the procedure and then bridged to Coumadin. He was discharged home three days later. Thrombi forming within large catheters used for structural heart interventions are usually multicausal, can have catastrophic consequences and should be avoided by constantly flushing the catheters as well as by aiming for a very high level of anticoagulation during the procedure. The optimal treatment remains controversial, including anticoagulation, thrombolysis, surgical thrombectomy and percutaneous thromboaspiration1.

Conflict of interest statement

J. Rodés-Cabau has received research grants from Edwards Lifesciences, Medtronic and Heart Leaflet Technologies. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Transoesophageal echocardiogram showing a giant, very mobile thrombus located in the right atrium.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiogram showing a giant, very mobile thrombus located in the right atrium.

Volume 14 Number 9
Oct 12, 2018
Volume 14 Number 9
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-18-00973 Apr 16, 2019
Percutaneous repair of healed endocarditis of the mitral valve using MitraClip devices around a large mobile vegetation
Ninios V et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY14M07_05 Jul 20, 2015
MitraClip repair of a “trileaflet” regurgitant mitral valve
Freixa X et al
free

State-of-the-Art

10.4244/EIJ-D-23-01084 Aug 19, 2024
Antithrombotic therapy for transcatheter structural heart intervention
Guedeney P et al
free

Image – Interventional flashlight

10.4244/EIJ-D-18-01094 Aug 29, 2019
En bloc aspiration of a giant lung embolism
Gori T
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00164 Jun 20, 2017
First transjugular edge-to-edge mitral valve repair with the MitraClip system
Fam N et al
free

10.4244/EIJV7I1A28 May 17, 2011
Valve thrombosis after transcatheter heart valve implantation
Tay E et al
free
Trending articles
334.45

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
83.8

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
37.95

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
30.05

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
28.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
28.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved